Skip to main content
Top
Published in: Digestive Diseases and Sciences 2/2008

01-02-2008 | Original Paper

Influence of E. coli Strain Nissle 1917 (EcN) on Intestinal Gas Dynamics and Abdominal Sensation

Authors: Ana Cristina Hernando-Harder, Rudolf von Bünau, Mahaluxmy Nadarajah, Manfred Vincenz Singer, Hermann Harder

Published in: Digestive Diseases and Sciences | Issue 2/2008

Login to get access

Abstract

E. coli strain Nissle 1917 (EcN) is a probiotic clinically used with various indications. However, especially at the beginning of treatment, some patients report abdominal bloating. In a prospective, randomized, double-blind study in 30 healthy individuals we assessed the influences of EcN on intestinal gas dynamics and abdominal sensation. After one week without medication volunteers orally received 2.5–25 × 109 colony-forming units of EcN or placebo per day for 21 days. EcN was well tolerated and did not significantly affect abdominal symptoms, stool frequency or stool consistency. During gas challenge at different days no difference in the perception scores (range from 0 = no perception to 6 = pain) was observed between the two groups: the mean perception score was 1.2 (SD 0.2) in the EcN group and 1.4 (SD 0.2) in the placebo group. EcN had no relevant influence on intestinal gas dynamics.
Literature
2.
go back to reference Schrezenmeir J, de Vrese M (2001) Probiotics, prebiotics, and synbiotics—approaching a definition. Am J Clin Nutr 73:361S–364SPubMed Schrezenmeir J, de Vrese M (2001) Probiotics, prebiotics, and synbiotics—approaching a definition. Am J Clin Nutr 73:361S–364SPubMed
3.
go back to reference Gionchetti P, Lammers KM, Rizzello F, Campieri M (2005) VSL#3: an analysis of basic and clinical contributions in probiotic therapeutics. Gastroenterol Clin North Am 34:499–513, ix-xCrossRef Gionchetti P, Lammers KM, Rizzello F, Campieri M (2005) VSL#3: an analysis of basic and clinical contributions in probiotic therapeutics. Gastroenterol Clin North Am 34:499–513, ix-xCrossRef
4.
go back to reference Gionchetti P, Rizzello F, Lammers KM, Morselli C, Sollazzi L, Davies S, Tambasco R, Calabrese C, Campieri M (2006) Antibiotics and probiotics in treatment of inflammatory bowel disease. World J Gastroenterol 12:3306–3313PubMed Gionchetti P, Rizzello F, Lammers KM, Morselli C, Sollazzi L, Davies S, Tambasco R, Calabrese C, Campieri M (2006) Antibiotics and probiotics in treatment of inflammatory bowel disease. World J Gastroenterol 12:3306–3313PubMed
5.
go back to reference Kruis W, Fric P, Pokrotnieks J, Lukas M, Fixa B, Kascak M, Kamm MA, Weismueller J, Beglinger C, Stolte M, Wolff C, Schulze J (2004) Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine. Gut 53:1617–1623PubMedCrossRef Kruis W, Fric P, Pokrotnieks J, Lukas M, Fixa B, Kascak M, Kamm MA, Weismueller J, Beglinger C, Stolte M, Wolff C, Schulze J (2004) Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine. Gut 53:1617–1623PubMedCrossRef
6.
go back to reference Resta-Lenert S, Barrett KE (2003) Live probiotics protect intestinal epithelial cells from the effects of infection with enteroinvasive Escherichia coli (EIEC). Gut 52:988–997PubMedCrossRef Resta-Lenert S, Barrett KE (2003) Live probiotics protect intestinal epithelial cells from the effects of infection with enteroinvasive Escherichia coli (EIEC). Gut 52:988–997PubMedCrossRef
7.
go back to reference Seksik P, Marteau P (2004) Probiotics in inflammatory bowel disease: controlled trials and perspectives. Therapie 59:83–87PubMedCrossRef Seksik P, Marteau P (2004) Probiotics in inflammatory bowel disease: controlled trials and perspectives. Therapie 59:83–87PubMedCrossRef
8.
go back to reference Vanderhoof JA (2000) Probiotics and intestinal inflammatory disorders in infants and children. J Pediatr Gastroenterol Nutr 30(Suppl 2):S34–S38PubMedCrossRef Vanderhoof JA (2000) Probiotics and intestinal inflammatory disorders in infants and children. J Pediatr Gastroenterol Nutr 30(Suppl 2):S34–S38PubMedCrossRef
9.
go back to reference Blum G, Marre R, Hacker J (1995) Properties of Escherichia coli strains of serotype O6. Infection 23:234–236PubMedCrossRef Blum G, Marre R, Hacker J (1995) Properties of Escherichia coli strains of serotype O6. Infection 23:234–236PubMedCrossRef
10.
go back to reference Kruis W, Schutz E, Fric P, Fixa B, Judmaier G, Stolte M (1997) Double-blind comparison of an oral Escherichia coli preparation and mesalazine in maintaining remission of ulcerative colitis. Aliment Pharmacol Ther 11:853–858PubMedCrossRef Kruis W, Schutz E, Fric P, Fixa B, Judmaier G, Stolte M (1997) Double-blind comparison of an oral Escherichia coli preparation and mesalazine in maintaining remission of ulcerative colitis. Aliment Pharmacol Ther 11:853–858PubMedCrossRef
11.
go back to reference Rembacken BJ, Snelling AM, Hawkey PM, Chalmers DM, Axon AT (1999) Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: a randomised trial. Lancet 354:635–639PubMedCrossRef Rembacken BJ, Snelling AM, Hawkey PM, Chalmers DM, Axon AT (1999) Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: a randomised trial. Lancet 354:635–639PubMedCrossRef
12.
go back to reference Henker J, Blokhin B, Bolbot YK, Maydannik VG, Jores L, Wolff C, Schulze J (1917) Successfull therapy of unspecific prolonged diarhoea in infants, toddlers with the probiotic E. coli strain Nissle Gastroenterology 130(4):A-315 Henker J, Blokhin B, Bolbot YK, Maydannik VG, Jores L, Wolff C, Schulze J (1917) Successfull therapy of unspecific prolonged diarhoea in infants, toddlers with the probiotic E. coli strain Nissle Gastroenterology 130(4):A-315
13.
go back to reference Henker J, Laass M, Blokhin BM, Bolbot YK, Maydannik VG, Elze M, Wolff C, Schulze J (2007) The probiotic Escherichia coli strain Nissle 1917 (EcN) stops acute diarrhoea in infants and toddlers. Eur J Pediatr 166:311–318PubMedCrossRef Henker J, Laass M, Blokhin BM, Bolbot YK, Maydannik VG, Elze M, Wolff C, Schulze J (2007) The probiotic Escherichia coli strain Nissle 1917 (EcN) stops acute diarrhoea in infants and toddlers. Eur J Pediatr 166:311–318PubMedCrossRef
14.
go back to reference Krammer HJ, Kamper H, von Bunau R, Zieseniss E, Stange C, Schlieger F, Clever I, Schulze J (2006) Probiotic drug therapy with E. coli strain Nissle 1917 (EcN): results of a prospective study of the records of 3807 patients. Z Gastroenterol 44:651–656PubMedCrossRef Krammer HJ, Kamper H, von Bunau R, Zieseniss E, Stange C, Schlieger F, Clever I, Schulze J (2006) Probiotic drug therapy with E. coli strain Nissle 1917 (EcN): results of a prospective study of the records of 3807 patients. Z Gastroenterol 44:651–656PubMedCrossRef
15.
go back to reference Serra J, Azpiroz F, Malagelada JR (1998) Intestinal gas dynamics and tolerance in humans. Gastroenterology 115:542–550PubMedCrossRef Serra J, Azpiroz F, Malagelada JR (1998) Intestinal gas dynamics and tolerance in humans. Gastroenterology 115:542–550PubMedCrossRef
16.
go back to reference Kim HJ, Camilleri M, McKinzie S, Lempke MB, Burton DD, Thomforde GM, Zinsmeister AR (2003) A randomized controlled trial of a probiotic, VSL#3, on gut transit and symptoms in diarrhoea-predominant irritable bowel syndrome. Aliment Pharmacol Ther 17:895–904PubMedCrossRef Kim HJ, Camilleri M, McKinzie S, Lempke MB, Burton DD, Thomforde GM, Zinsmeister AR (2003) A randomized controlled trial of a probiotic, VSL#3, on gut transit and symptoms in diarrhoea-predominant irritable bowel syndrome. Aliment Pharmacol Ther 17:895–904PubMedCrossRef
17.
go back to reference Nobaek S, Johansson ML, Molin G, Ahrne S, Jeppsson B (2000) Alteration of intestinal microflora is associated with reduction in abdominal bloating and pain in patients with irritable bowel syndrome. Am J Gastroenterol 95:1231–1238PubMedCrossRef Nobaek S, Johansson ML, Molin G, Ahrne S, Jeppsson B (2000) Alteration of intestinal microflora is associated with reduction in abdominal bloating and pain in patients with irritable bowel syndrome. Am J Gastroenterol 95:1231–1238PubMedCrossRef
18.
go back to reference Mollenbrink M, Bruckschen E (1994) Treatment of chronic constipation with physiologic Escherichia coli bacteria. Results of a clinical study of the effectiveness and tolerance of microbiological therapy with the E. coli Nissle 1917 strain (Mutaflor). Med Klin (Munich) 89:587–593 Mollenbrink M, Bruckschen E (1994) Treatment of chronic constipation with physiologic Escherichia coli bacteria. Results of a clinical study of the effectiveness and tolerance of microbiological therapy with the E. coli Nissle 1917 strain (Mutaflor). Med Klin (Munich) 89:587–593
19.
go back to reference Levitt MD, Furne J, Olsson S (1996) The relation of passage of gas and abdominal bloating to colonic gas production. Ann Intern Med 124:422–424PubMed Levitt MD, Furne J, Olsson S (1996) The relation of passage of gas and abdominal bloating to colonic gas production. Ann Intern Med 124:422–424PubMed
20.
go back to reference Niedzielin K, Kordecki H, Birkenfeld B (2001) A controlled, double-blind, randomized study on the efficacy of Lactobacillus plantarum 299V in patients with irritable bowel syndrome. Eur J Gastroenterol Hepatol 13:1143–1147PubMedCrossRef Niedzielin K, Kordecki H, Birkenfeld B (2001) A controlled, double-blind, randomized study on the efficacy of Lactobacillus plantarum 299V in patients with irritable bowel syndrome. Eur J Gastroenterol Hepatol 13:1143–1147PubMedCrossRef
21.
go back to reference Serra J, Azpiroz F, Malagelada JR (2001) Mechanisms of intestinal gas retention in humans: impaired propulsion versus obstructed evacuation. Am J Physiol Gastrointest Liver Physiol 281:G138–G143PubMed Serra J, Azpiroz F, Malagelada JR (2001) Mechanisms of intestinal gas retention in humans: impaired propulsion versus obstructed evacuation. Am J Physiol Gastrointest Liver Physiol 281:G138–G143PubMed
22.
go back to reference Serra J, Azpiroz F, Malagelada JR (2001) Impaired transit and tolerance of intestinal gas in the irritable bowel syndrome. Gut 48:14–19PubMedCrossRef Serra J, Azpiroz F, Malagelada JR (2001) Impaired transit and tolerance of intestinal gas in the irritable bowel syndrome. Gut 48:14–19PubMedCrossRef
23.
go back to reference Harder H, Serra J, Azpiroz F, Passos MC, Aguade S, Malagelada JR (2003) Intestinal gas distribution determines abdominal symptoms. Gut 52:1708–1713PubMedCrossRef Harder H, Serra J, Azpiroz F, Passos MC, Aguade S, Malagelada JR (2003) Intestinal gas distribution determines abdominal symptoms. Gut 52:1708–1713PubMedCrossRef
24.
go back to reference Harder H, Serra J, Azpiroz F, Malagelada JR (2004) Reflex control of intestinal gas dynamics and tolerance in humans. Am J Physiol Gastrointest Liver Physiol 286:G89–G94PubMedCrossRef Harder H, Serra J, Azpiroz F, Malagelada JR (2004) Reflex control of intestinal gas dynamics and tolerance in humans. Am J Physiol Gastrointest Liver Physiol 286:G89–G94PubMedCrossRef
25.
go back to reference Houghton LA, Lea R, Agrawal A, Reilly B, Whorwell PJ (2006) Relationship of abdominal bloating to distention in irritable bowel syndrome and effect of bowel habit. Gastroenterology 131:1003–1010PubMedCrossRef Houghton LA, Lea R, Agrawal A, Reilly B, Whorwell PJ (2006) Relationship of abdominal bloating to distention in irritable bowel syndrome and effect of bowel habit. Gastroenterology 131:1003–1010PubMedCrossRef
26.
go back to reference Azpiroz F, Malagelada JR (2005) The pathogenesis of bloating and visible distension in irritable bowel syndrome. Gastroenterol Clin North Am 34:257–269CrossRef Azpiroz F, Malagelada JR (2005) The pathogenesis of bloating and visible distension in irritable bowel syndrome. Gastroenterol Clin North Am 34:257–269CrossRef
28.
go back to reference Azpiroz F, Serra J (2004) Treatment of excessive intestinal gas. Curr Treat Options Gastroenterol 7:299–305PubMedCrossRef Azpiroz F, Serra J (2004) Treatment of excessive intestinal gas. Curr Treat Options Gastroenterol 7:299–305PubMedCrossRef
29.
Metadata
Title
Influence of E. coli Strain Nissle 1917 (EcN) on Intestinal Gas Dynamics and Abdominal Sensation
Authors
Ana Cristina Hernando-Harder
Rudolf von Bünau
Mahaluxmy Nadarajah
Manfred Vincenz Singer
Hermann Harder
Publication date
01-02-2008
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 2/2008
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-007-9892-3

Other articles of this Issue 2/2008

Digestive Diseases and Sciences 2/2008 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.